rs3738668

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032793.5(MFSD2A):​c.-246C>A variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0726 in 370,050 control chromosomes in the GnomAD database, including 3,997 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 1134 hom., cov: 31)
Exomes 𝑓: 0.068 ( 2863 hom. )

Consequence

MFSD2A
NM_032793.5 upstream_gene

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.132

Publications

3 publications found
Variant links:
Genes affected
MFSD2A (HGNC:25897): (MFSD2 lysolipid transporter A, lysophospholipid) The protein encoded by this gene is a transmembrane protein and sodium-dependent lysophosphatidylcholine transporter. The encoded protein is involved in the establishment of the blood-brain barrier and is required for brain growth and function. Defects in this gene are a cause of a progressive microcephaly syndrome. [provided by RefSeq, Mar 2017]
MFSD2A Gene-Disease associations (from GenCC):
  • microcephaly 15, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032793.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 1-39955047-C-A is Benign according to our data. Variant chr1-39955047-C-A is described in ClinVar as Benign. ClinVar VariationId is 1223952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.427 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032793.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD2A
NM_032793.5
MANE Select
c.-246C>A
upstream_gene
N/ANP_116182.2
MFSD2A
NM_001136493.3
c.-246C>A
upstream_gene
N/ANP_001129965.1Q8NA29-1
MFSD2A
NM_001349821.2
c.-246C>A
upstream_gene
N/ANP_001336750.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MFSD2A
ENST00000372811.10
TSL:1 MANE Select
c.-246C>A
upstream_gene
N/AENSP00000361898.6Q8NA29-2
MFSD2A
ENST00000483824.5
TSL:1
n.-111C>A
upstream_gene
N/A
MFSD2A
ENST00000372809.5
TSL:2
c.-246C>A
upstream_gene
N/AENSP00000361895.5Q8NA29-1

Frequencies

GnomAD3 genomes
AF:
0.0790
AC:
11942
AN:
151172
Hom.:
1128
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.442
Gnomad SAS
AF:
0.0746
Gnomad FIN
AF:
0.0390
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00488
Gnomad OTH
AF:
0.0749
GnomAD4 exome
AF:
0.0681
AC:
14891
AN:
218760
Hom.:
2863
AF XY:
0.0649
AC XY:
7193
AN XY:
110810
show subpopulations
African (AFR)
AF:
0.162
AC:
1049
AN:
6484
American (AMR)
AF:
0.132
AC:
839
AN:
6362
Ashkenazi Jewish (ASJ)
AF:
0.0114
AC:
96
AN:
8428
East Asian (EAS)
AF:
0.499
AC:
10297
AN:
20654
South Asian (SAS)
AF:
0.0697
AC:
150
AN:
2152
European-Finnish (FIN)
AF:
0.0389
AC:
712
AN:
18298
Middle Eastern (MID)
AF:
0.0189
AC:
22
AN:
1164
European-Non Finnish (NFE)
AF:
0.00520
AC:
731
AN:
140554
Other (OTH)
AF:
0.0679
AC:
995
AN:
14664
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
426
852
1279
1705
2131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
11968
AN:
151290
Hom.:
1134
Cov.:
31
AF XY:
0.0833
AC XY:
6154
AN XY:
73880
show subpopulations
African (AFR)
AF:
0.160
AC:
6601
AN:
41182
American (AMR)
AF:
0.122
AC:
1850
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3462
East Asian (EAS)
AF:
0.443
AC:
2221
AN:
5018
South Asian (SAS)
AF:
0.0740
AC:
352
AN:
4754
European-Finnish (FIN)
AF:
0.0390
AC:
411
AN:
10528
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00488
AC:
331
AN:
67840
Other (OTH)
AF:
0.0750
AC:
157
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
464
928
1393
1857
2321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0443
Hom.:
79
Bravo
AF:
0.0914
Asia WGS
AF:
0.272
AC:
944
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
11
DANN
Benign
0.91
PhyloP100
-0.13
PromoterAI
-0.099
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3738668;
hg19: chr1-40420719;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.